http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101289033-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-366 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-351 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-366 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D309-38 |
| filingDate | 2011-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101289033-B1 |
| titleOfInvention | Cancer stem cell growth inhibitory composition |
| abstract | The present invention relates to a cancer stem cell growth inhibitor containing a 2-pyrone-derived compound as an active ingredient, more specifically, cancer stem by inhibiting PI3K signaling activity and inhibiting Ras signal through Ras-Raf-ERK signaling system The present invention relates to the use of 2-pyrone-derived compounds that inhibit cell maintenance, malignance and invasive activity. In addition, the 2-pyrone pyron compound of the present invention as an anticancer adjuvant according to cancer stem cell inhibition, can be usefully used for the treatment and prevention of cancer diseases. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11324706-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017188690-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101907151-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101724541-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20170130278-A |
| priorityDate | 2011-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 232.